Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology... see more

Bullboard (TSX:CPH)

View:
Post by Jonathon Brownon Nov 21, 2024 6:55am

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

Comment by Daudau11on Nov 12, 2024 5:01pm

RE:RE:Stifel

Tbh, I don't see any stocks I own doing well lately.  The only things that are going up nowadays are,  Tech/AI and Crypto.  Thats like it.  Seems like the the market believes ...more  
Comment by drewmumawon Nov 12, 2024 4:05pm

RE:Stifel

I had some time to scan the MD&A today. Let me know if I'm missing anything major, but my key takeaways were: Natroba strongly boosted product revenue. It only has 22% of the US market ...more  
Post by retiredcfon Nov 12, 2024 6:52am

Stifel

Cipher Pharmaceuticals Target Lowered by Stifel Nicolaus C$19.00 C$17.00
Comment by retiredcfon Nov 05, 2024 2:08pm

RE:Raised Target

Can't see any reason why the SP has fallen almost 17% in the past 3 weeks other than profit taking or investor jitters. Hopefully the upcoming earnings will reverse the trend. GLTA
Post by retiredcfon Oct 25, 2024 8:41am

Raised Target

Cipher Pharmaceuticals Target Raised by Stifel Nicolaus C$17.00 C$19.00
Post by retiredcfon Oct 15, 2024 9:26am

Ink Research

The INK CIN Index leaders last week were Bird Construction (Sunny; BDT), up 23.4%, Cipher Pharmaceuticals (Sunny; CPH), up 13.6%, and CI Financial (Mostly Sunny; CIX), up 9.8%. The laggards were Aura ...more  
Post by retiredcfon Oct 10, 2024 10:29am

Good Looking Hire

"I am delighted to announce the addition of Dr. Ghanei to Cipher's executive team. Hamed's expertise in business development, including extensive experience with licensing deals and other ...more  
Comment by Possibleidiot01on Oct 01, 2024 7:26pm

RE:Planet Microcap Presentation CPH

The Q+A isn't the best part of the presentation - seems like leading questiions were asked and you YES/NO answers until the last one which is about the milestone payments due to Moberg and if i ...more  
Post by Possibleidiot01on Oct 01, 2024 12:13pm

Dean@PettyCash , Substack

https://pettycash.substack.com/p/cph-update
Post by Daudau11on Sep 26, 2024 5:38pm

Planet Microcap Presentation CPH

https://www.webcaster4.com/Player/Index?webcastId=51093&g=2ec8b265-0753-4352-b554-2277e4cbfaaf&uid=6209799&sid=
Comment by Daudau11on Sep 26, 2024 10:56am

RE:Stifel Raises Target

Haha raised target yesterday and it was flatish and today dropped below $14 
Post by retiredcfon Sep 25, 2024 9:17am

Stifel Raises Target

Stifel’s Justin Keywood moves his Cipher Pharmaceuticals Inc.  target to $17 from $16 with a “buy” rating. The average is $17.63. “We raise our target price ... to reflect increased confidence ...more  
Comment by drewmumawon Sep 18, 2024 10:18am

RE:RE:RE:RE:RE:RE:RE:Hits after hits on Small Caps

I wasn't on the call, unfortunately, so that's why I was asking. There's an interview with the Moberg CEO on Redeye, but it's in Swedish. https://www.redeye.se/research/1039785/moberg ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities